Medscape | Obinutuzumab Active in Elderly Chronic Lymphocytic Leukemia Medscape Obinutuzumab is a new monoclonal antibody directed against CD20, which is also targeted by rituximab (Rituximab, Genentech/Roche). However, obinutuzumab is a humanized antibody and has shown less propensity for immune reactions in preclinical ... |
